DANIEL ERNESTO
CASTELLANO GAUNA
Profesor asociado
Felipe
Villacampa Aubá
Publications by the researcher in collaboration with Felipe Villacampa Aubá (14)
2022
2020
-
Re: Inhibition of a G9a/DNMT Network Triggers Immune-Mediated Bladder Cancer Regression
Journal of Urology
-
miRNA profiling in renal carcinoma suggest the existence of a group of pro-angionenic tumors in localized clear cell renal carcinoma
PloS one, Vol. 15, Núm. 2, pp. e0229075
2019
-
CDK4/6 inhibitor as a novel therapeutic approach for advanced bladder cancer independently of RB1 status
Clinical Cancer Research, Vol. 25, Núm. 1, pp. 390-402
-
Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression
Nature Medicine
2018
-
Mitomycin C HIVEC. Update and results in high risk patients
Archivos Espanoles de Urologia, Vol. 71, Núm. 4, pp. 417-425
2017
-
BMP4 induces M2 macrophage polarization and favors tumor progression in bladder cancer
Clinical Cancer Research, Vol. 23, Núm. 23, pp. 7388-7399
-
Opposing roles of PIK3CA gene alterations to EZH2 signaling in non-muscle invasive bladder cancer
Oncotarget, Vol. 8, Núm. 6, pp. 10531-10542
-
Urothelial cancer proteomics provides both prognostic and functional information
Scientific Reports, Vol. 7, Núm. 1
2015
-
A Polycomb-mir200 loop regulates clinical outcome in bladder cancer
Oncotarget, Vol. 6, Núm. 39, pp. 42258-42275
-
Analysis of the polycomb-related lncRNAs HOTAIR and ANRIL in bladder cancer
Clinical Epigenetics, Vol. 7, Núm. 1
-
PIK3CA gene alterations in bladder cancer are frequent and associate with reduced recurrence in non-muscle invasive tumors
Molecular Carcinogenesis, Vol. 54, Núm. 7, pp. 566-576
2014
-
In vivo disruption of an Rb-E2F-Ezh2 signaling loop causes bladder cancer
Cancer Research, Vol. 74, Núm. 22, pp. 6565-6577
2011
-
Testicular tumors: Residual retroperitoneal mass surgery after chemotherapy; ¿is it possible to predict their histology?
Archivos Espanoles de Urologia, Vol. 64, Núm. 7, pp. 611-619